The results of the study demonstrated that treatment with BPC-157 peptide significantly reduced the severity of colitis in rats. The rats treated with BPC-157 peptide showed reduced inflammation, improved tissue healing, and increased expression of genes involved in tissue repair. The study also demonstrated that BPC-157 peptide has the ability to stabilize endothelial barrier function, leading to reduced inflammation and improved tissue healing.
Link to the full study here



